Education
About Us
Working with TipRanks
Follow Us
N4 Pharma (GB:N4P)
:N4P
N4P Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.37p - 0.92p
Previous CloseN/A
Volume555.10K
Average Volume (3M)996.32K
Market Cap
£4.61M
Enterprise Value37.15K
Total Cash (Recent Filing)£793.14K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Sep 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding394,780,330
10 Day Avg. Volume837,546
30 Day Avg. Volume996,315
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)320.06
Price to Cash Flow (P/CF)-2.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
N4 Pharma News
PremiumCompany Announcements
N4 Pharma Raises £1.75 Million to Advance Nuvec® Platform
PremiumCompany Announcements
N4 Pharma PLC Announces Change in Major Shareholdings
PremiumCompany Announcements
N4 Pharma Schedules Investor Presentation on RNA Therapeutic Development
PremiumCompany Announcements
N4 Pharma Strengthens Board with Strategic Appointment of Dr. Alastair Smith
PremiumCompany Announcements
N4 Pharma’s New Patent Targets IBD TreatmentPremiumCompany Announcements
N4 Pharma Grants 15 Million Options to Key DirectorsPremiumCompany Announcements
N4 Pharma Engages Investors with CEO Q&A Session---
N4P FAQ
What was N4 Pharma’s price range in the past 12 months?
N4 Pharma lowest share price was 0.36p and its highest was 0.92p in the past 12 months.
What is N4 Pharma’s market cap?
N4 Pharma’s market cap is £4.61M.
When is N4 Pharma’s upcoming earnings report date?
N4 Pharma’s upcoming earnings report date is Sep 17, 2025 which is in 167 days.
How were N4 Pharma’s earnings last quarter?
Currently, no data Available
Is N4 Pharma overvalued?
According to Wall Street analysts N4 Pharma’s price is currently Overvalued.
Does N4 Pharma pay dividends?
N4 Pharma does not currently pay dividends.
What is N4 Pharma’s EPS estimate?
N4 Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does N4 Pharma have?
N4 Pharma has 394,780,330 shares outstanding.
What happened to N4 Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of N4 Pharma?
Currently, no hedge funds are holding shares in GB:N4P
---
Company Description
N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
---
Technical Analysis
---